# Combined Bio- and Neuro- Feedback vs. Varenicline Use for Smoking Cessation

> **NCT02991781** · NA · COMPLETED · sponsor: **Aristotle University Of Thessaloniki** · enrollment: 106 (actual)

## Conditions studied

- Chronic Obstructive Pulmonary Disease (COPD)
- Asthma
- Smoking

## Interventions

- **OTHER:** Biofeedback and Neurofeedback Training
- **DRUG:** Varenicline use for smoking cessation
- **OTHER:** Sham Neurofeedback
- **OTHER:** Passive Control

## Key facts

- **NCT ID:** NCT02991781
- **Lead sponsor:** Aristotle University Of Thessaloniki
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-01
- **Primary completion:** 2019-06
- **Final completion:** 2019-06
- **Target enrollment:** 106 (ACTUAL)
- **Last updated:** 2020-02-17

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02991781

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02991781, "Combined Bio- and Neuro- Feedback vs. Varenicline Use for Smoking Cessation". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT02991781. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*